Bogus HIV tests
This article was originally published in The Tan Sheet
Executive Summary
Federal Trade Commission settles charges against Medford, N.Y.-based Chembio Diagnostic Systems and San Diego-based Alfa Scientific Designs alleging the firms made false claims about the accuracy of unapproved rapid HIV antibody tests. Settlement bars defendants from making or assisting others in making false or misleading representations concerning the accuracy of any unapproved HIV test or other unapproved device. Over the past two years, FTC has settled similar charges against distributors of both the Chembio and Alfa tests, however latest action is first brought against manufacturers of such tests
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning